The Académie de Médecine flies to the aid of vape

FIVAPE Category Studies

In a press release published on December 6, the Académie de Médecine issued a much-needed corrective to the unfair confusion that has plagued vape products in recent months. Here it is:

The French National Academy of Medicine recalls the proven benefits and unduly alleged drawbacks of electronic cigarettes (vaporette)

Confidence in e-cigarettes has now been shaken by the observation of a sudden epidemic of lung pathologies localized in the United States, as well as by the report from the World Health Organization (WHO), which without argument describes e-cigarettes as "indisputably harmful". The position expressed by the Academy in 2015 advised guaranteeing product safety, declaring the substances present in e-liquids and, above all, banning their sale to minors, as well as advertising and use where smoking is prohibited. This is the case today in France, where electronic cigarettes are subject to quality and safety standards, unlike in the United States.

This crisis of confidence could lead to the death of thousands of smokers, while tobacco kills half of its faithful consumers. Don't confuse the harmful container with the toxicity of the contents.
The American epidemic of lung damage is due to a detour of its use because, after blaming vaping as such, the Center for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recognize that this detour is the main cause of this epidemic, which affected almost 2,200 people in four months, with 42 deaths. We shouldn't accuse the container of being harmful, when it's the content that is actually harmful and responsible for the American alert.

Vaporettes, which are less dangerous than cigarettes, help people to stop and reduce their tobacco consumption. 700,000 smokers have quit smoking thanks to vaporettes.

It is well established that vaping is less harmful than smoking: As the National Academy of Medicine noted as early as 2015, it is therefore preferable for a smoker to vape. Since 2016, the French National Authority for Health (HAS) has considered e-cigarettes “an aid to help smokers quit or reduce their tobacco use,” sometimes more effectively than other nicotine replacement therapies, as demonstrated by a randomized trial. Santé Publique France reports that at least 700,000 smokers have quit thanks to e-cigarettes. While concerns are entirely justified in the U.S., this is not the case in France, as data from Paris Sans Tabac ( Studies ) show that overall nicotine consumption among young people—including both vaping and smoking—is decreasing thanks to French and European regulations. The epidemic of misuse among young people serves as a reminder to Americans that they have failed to adequately regulate its use. This lack of regulation explains this crisis, just as it did with the opioid crisis. In France, many smokers who were considering switching to e-cigarettes instead of tobacco should not hesitate, since the HAS has recognized it as a useful and proven tool for smoking cessation.

The French National Academy of Medicine warns against making the wrong enemy!

Source : http://www.academie-medecine.fr/lacademie-nationale-de-medecine-rappelle-les-avantages-prouves-et-les-inconvenients-indument-allegues-de-la-cigarette-electronique-vaporette/?fbclid=IwAR0N518Z9JX-2qbNEuzxFpvQ4TdlKehLXUrgodc6FExKql3XVNANx-GTz0Q